Clinical Utility of COVID-19 Real Time-Polymerase Chain Reaction Testing of Ocular Tissues of Non–COVID-19 Cornea Donors Deemed Suitable for Corneal Retrieval and Transplantation
Conclusions:
The overall prevalence of SARS-CoV-2 was 1% (2% for conjunctival and 0% for corneal samples, P value = 0.5) in the donors who were found suitable for cornea recovery and transplantation. The findings of exceptionally low positive rates in our samples validate the criticality of history-based donor screening and do not support the necessity of postmortem PCR testing as a criterion for procurement and subsequent use for corneal transplantation.
Source: Cornea - Category: Opthalmology Tags: Basic Investigation Source Type: research
More News: Cancer & Oncology | Corneal Transplant | COVID-19 | Depression | Opthalmology | SARS | Study | Suicide | Transplants